AXGN Stock Analysis: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
$40.99
0.04 (0.10%)
▲
5d:
-2.54%
30d:
+9.69%
90d:
+23.35%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 28, 2026
0d
Smart Money Accumulation
AXGN is down 5.7% this week, but smart money is accumulating calls. Top strike: $40 2026-07-17 with 85 OI. Call ratio: 100% View Scanner →
Strength: 7.8/10
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called AXGN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AXGN shows positive signals but monitor for confirmation. Market pricing in 0.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: AXGN shows positive signals but monitor for confirmation. Market pricing in 0.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.46
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.02
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXGN is currently trading at $40.99, which is considered slightly high relative to its 30-day fair value range of $35.74 to $42.72. The stock's valuation (Forward PE: 56.3) is in line with its historical norms (55.5). At these levels, the market is pricing in 0.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AXGN is in a strong uptrend. Immediate support is located at $39.52, while resistance sits at $44.45.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (16th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $50.78 (+23.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AXGN is in a strong uptrend. Immediate support is located at $39.52, while resistance sits at $44.45.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (16th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $50.78 (+23.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$35.74 -
$42.72
Company Quality Score
50/100
(HOLD)
Options IV Signal
16th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
72.7%
All Signals
- BULLISH: Options cheap (IV 16th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.9% below Wall St target ($50.78)
- NEUTRAL: Market pricing in 0.5% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$35.74 -
$42.72
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$3.18
(7.8%)
Support & Resistance Levels
Support Level
$39.52
Resistance Level
$44.45
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
56.28
Wall Street Target
$50.78
(+23.9%)
Revenue Growth (YoY)
26.6%
Profit Margin
-13.2%
Valuation Premium vs History
+0.5% premium
PE vs Historical
56.3 vs 55.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.5%
(market-implied from PE analysis)
1-Year Target
$41.19
(+1%)
2-Year Target
$41.40
(+1%)
3-Year Target
$41.61
(+2%)
3-Yr Target (if PE normalizes)
(PE: 56→56)
PE COMPRESSION
$41.03
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 56.3, Growth: 49.1%)
$135.75
(+231%)
Base:
(SPY PE: 22.1, Growth: 49.1%)
$53.23
(+30%)
Bear:
(PE: 18.8, Growth: 49.1%)
$45.25
(+10%)
Share & Embed Analysis
Last updated: May 18, 2026 4:15 AM ET
Data refreshes hourly during market hours. Next update: 5:15 AM
Data refreshes hourly during market hours. Next update: 5:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Erick Wayne Devinney
SELL
5221 shares
2026-03-16
Amy Mcbride Wendell
SELL
43684 shares
2025-12-16
Kathy Johnson Weiler
SELL
46653 shares
2025-12-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.
